相关实验视频
Updated: Jan 10, 2026
09:55
Three-Dimensional Imaging of Aortic Tissues in Atherosclerosis
Published on: October 25, 2024
1.4K
Ythdc1-p300-Klf5复杂介导的高尔基功能障碍促进大动脉动脉瘤
Wen-Li Wang1,2, Zhi-Xue Song1, Si-Ming Bu1
1Department of Biochemistry and Molecular Biology, Key Laboratory of Neural and Vascular Biology, Ministry of Education, and Hebei Key Laboratory of Cardiovascular Homeostasis and Aging, Hebei Medical University, Shijiazhuang, Hebei, 050017, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 29, 2025
概括
Klf5上调 Golph3l,促进 Golgi 紧缩和血管光滑肌细胞的亡诱导的增殖,推动大动脉动脉瘤的发展. 针对这种途径为大动脉疾病提供了潜在的治疗策略.
科学领域:
- 血管生物学 血管生物学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- Klf5和Golph3l调节戈尔基形态,影响血管光滑肌细胞 (VSMC) 亡,并导致大动脉动脉瘤.
- 连接Klf5,Golph3l和Golgi动脉瘤变化的精确分子机制仍然难以捉摸.
研究的目的:
- 在大动脉动脉瘤的背景下阐明Klf5,Golph3l和Golgi形态之间的分子联系.
- 为了研究由亡诱导的扩散 (AIP) 在大动脉解剖 (AD) 和动脉瘤期间在VSMC中的作用.
- 确定对大动脉动脉瘤的治疗点.
主要方法:
- 研究了Klf5和Golph3l在VSMC亡和Golgi形态学中的作用.
- 分析了对VSMCs的 ангиотензинII (AngII) 刺激效应.
- 研究了m6ARNA修饰,特别是m6A-Gm40097,以及它与Klf5,Ythdc1和p300的相互作用.
- 开发了一个预测性网站,用于AD患者的治疗结果.
主要成果:
- 在VSMC中观察到由亡诱导的扩散 (AIP) 在人类和小鼠的AD和动脉瘤中.
- Klf5诱导的Golph3l上调驱动Golgi紧缩,促进TNF-α和TNFSF12分泌,这对于AIP和动脉瘤至关重要.
- 由AngII诱导的m6ARNA升高,特别是m6A-Gm40097,可以提高Golph3l的调节,并促进AIP.
- m6A-Gm40097促进Klf5-Ythdc1-p300复合体在Golph3l促进体上形成,从而激活转录.
- 建立了一个预测术后阿尔茨海默病死亡率的网站.
结论:
- 发现了一种涉及 lncRNA m6A 修改,染色体重塑和转录激活的新型调节机制.
- 准Ythdc1-p300-Klf5复合体为戈尔吉功能障碍和大动脉动脉瘤提供了潜在的治疗策略.
- 这些发现提供了关于AD病原体和风险分层的见解.
关键词:
这是AAAAAAAA的意思.AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD AD ADD was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was was高尔夫球的第一个.在KLF5KLF5KLF5KLF5m6A VSMCC 的时间
相关概念视频
01:30Aneurysm I: Introduction
320
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
320
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
374
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
382
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
382
01:15Aortic Regurgitation I: Introduction
438
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
438
01:23Cystic Fibrosis: Pathogenesis
680
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
680